@inproceedings{OpazoBasaezGhulamAriasArandaetal.2014, author = {Opazo Basaez, Marco and Ghulam, Sarfaraz and Arias Aranda, Daniel and Stantchev, Vladimir}, title = {Smart healthcare services: a patient oriented cloud computing solution}, pages = {18}, year = {2014}, abstract = {Objectives/rationale: Healthcare systems all over the world are facing difficult challenges that have a direct impact and influence the delivery of healthcare services. As a response healthcare institutions are relying in the implementation of Information and communication technologies (ICTs) to overcome difficulties and satisfy patients' demands in a cost-effective way adopting new technologies capable to innovate, extend, and redefine the way healthcare has been delivered for decades. New technological innovations such as Internet of things (IoT), Smart item technology, and cloud computing can improve the traditional e-healthcare system and extend service provision beyond the hospital facilities by using wireless sensor networks (WSN) and radio frequency identification devices (RFID), providing a new type of services advertised as "smart." This type of services, enable doctors to treat patients remotely and allows people to do their normal daily routines, occupations, and activities while receiving appropriate, timely, and high-quality ubiquitous healthcare services. Methods: An exploratory study is performed to review the route towards smart healthcare services, emphasizing the use of information and communication technologies (ICTs) and smart item technology as enhancers for smart healthcare services provision. Results/findings: A new technological infrastructure promises to transform medical practice and disease prevention by empowering healthcare institutions with smart items for remote patient monitoring eliminating time-wasting procedures, reducing health costs, improving quality of service and patients satisfaction. Implications/conclusions: Traditional e-healthcare system is transitioning into an interconnected smart-healthcare system potentiated by new technological advances capable to extend healthcare service provision and offer smart healthcare services.}, language = {en} } @inproceedings{GhulamSchubertTammetal.2014, author = {Ghulam, Sarfaraz and Schubert, Johannes and Tamm, Gerrit and Stantchev, Vladimir}, title = {Integrating Smart Items and Cloud Computing in Healthcare Scenarios}, pages = {7}, year = {2014}, abstract = {Use of cloud computing in healthcare is a promising trend, particularly in utilization of smart items. Access, affordability and quality to proper healthcare is a great challenge in world society. With the utilization of smart sensors, there are possibilities to improve the quality of healthcare services whenever needed. Hence, such smart items services lead to economic advantages for the whole healthcare system. Keeping in mind these opportunities as well as challenges such as security or legal issues, it is important to bring healthcare and IT together. As a result, healthcare business processes need to be modeled in order to provide IT solutions tailored for practice-oriented applications. In this paper, we present a three-level architecture for a smart healthcare infrastructure. Our approach is based on recent literature work and results from conducted expert interviews with healthcare specialists and IT professionals. To demonstrate the applicability of this architecture model, we provide an example use-case as a template for any kind of smart sensor-based healthcare infrastructure.}, language = {en} } @inproceedings{Hessel2012, author = {Hessel, Franz}, title = {Economic Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement}, series = {ISPOR 15th Annual European Congress, Berlin}, booktitle = {ISPOR 15th Annual European Congress, Berlin}, year = {2012}, abstract = {Keine Angabe - No details}, language = {en} } @inproceedings{Hessel2013, author = {Hessel, Franz}, title = {Gesundheits{\"o}konomische Analyse der Thromboseprophylaxe mit Ribaroxaban im Vergleich zu Certoparin nach H{\"u}ft- und Kniegelenks-Endoprothesen-Operation aus Sicht einer Universit{\"a}tsklinik}, series = {Jahrestagung der Deutschen Gesellschaft f{\"u}r Gesundheits{\"o}konomie (DGG{\"O}), Essen}, booktitle = {Jahrestagung der Deutschen Gesellschaft f{\"u}r Gesundheits{\"o}konomie (DGG{\"O}), Essen}, year = {2013}, abstract = {Keine Angabe - No details}, language = {de} } @inproceedings{Hessel2013, author = {Hessel, Franz}, title = {Die Machbarkeit der Erhebung der Zahlungsbereitschaft {\"u}ber soziale Netzwerke am Beispiel von Darmkrebs-Screening}, series = {Jahrestagung der Deutschen Gesellschaft f{\"u}r Gesundheits{\"o}konomie (DGG{\"O}), Essen}, booktitle = {Jahrestagung der Deutschen Gesellschaft f{\"u}r Gesundheits{\"o}konomie (DGG{\"O}), Essen}, year = {2013}, abstract = {Zielsetzung: Die Zielsetzung der vorliegenden Studie war es, die Machbarkeit der Erhebung der Zahlungsbereitschaft {\"u}ber soziale Netzwerke, hier Facebook, am Beispiel des Darmkrebs-Screenings zu untersuchen. Bei dem beschriebenen neuen diagnostischen Test handelt es sich um den neuartigen molekularen Bluttest Septin9, der im Vergleich zu standardm{\"a}ssig f{\"u}r Routinescreening auf Darmkrebs eingesetzten Test auf okkultes Blut im Stuhl (FOBT) eine bessere Performance, eine bessere Handhabbarkeit und eine bessere Compliance von Patienten und {\"A}rzten aufweist. Methodik: Es wurden Informationen zum Krankheitsbild und den alternativen Screeningmethoden f{\"u}r Darmkrebs gegeben. Die Zahlungsbereitschaft wurde in bin{\"a}ren Kategorien (<100 oder >100 EUR) und als H{\"o}chstbetrag erfasst. Die weiteren Parameter wie Alter, Geschlecht, Versicherten- und Einkommensstatus, Ern{\"a}hrung, Kontakt mit Krebserkrankungen und gesundheitsbewusstes Verhalten (Alkohol, Rauchen) wurden in Kategorien erfasst. Die Befragung wurde von sechs Facebook-Accounts an insgesamt rund 500 Nutzer des sozialen Netzwerks mit der M{\"o}glichkeit der weiteren Distribution versandt. Die Beantwortung eines Kern-Teils der Fragen wurde als Bedingung f{\"u}r die anonyme Einsendung {\"u}ber einen Dropbox-Link vorausgesetzt. Der R{\"u}cklaufzeitraum betrug 14 Tage. Ergebnisse: Es gingen 123 komplett ausgef{\"u}llte Frageb{\"o}gen ein. Die Teilnehmer waren im Schnitt 24,2 Jahre und verdienen zu 94 \% weniger als 1500 EUR monatlich. 27 \% der Teilnehmer sind privat versichert. 68\% gaben an in der Familie von Krebs betroffen zu sein und 36 \%, dass sie sich der Gefahr von Darmkrebs bewusst sind. Die Angaben zum wichtigsten Attribut eines Screening-Tests verteilten sich folgendermaßen: 69 \% Testgenauigkeit, 14 \% Handling, 11 \% Preis und 6\% Schnelligkeit des Ergebnisses. 24 \% gaben eine Zahlungsbereitschaft von weniger als 100 EUR an (Mittelwert 34 EUR), 76 \% waren bereit mehr als 100 EUR zu bezahlen. Die durchschnittliche Zahlungsbereitschaft lag bei 271 EUR. Ein h{\"o}heres Einkommen, eine Krebserkrankung in der Familie und ein Privatversichertenstatus waren mit einer h{\"o}heren Zahlungsbereitschaft korreliert. Schlussfolgerung: Eine Messung der Zahlungsbereitschaft sowie weiterer die Patientenpr{\"a}ferenzen beschreibender Variablen ist {\"u}ber soziale Netzwerke mit vergleichsweise geringem Aufwand m{\"o}glich. Vorteile liegen in der Freiwilligkeit und der Anonymit{\"a}t der Erhebung, wodurch direkte, nicht standardisierte Beeinflussungsm{\"o}glichkeiten w{\"a}hrend der Befragung als Bias wegfallen. Nachteile liegen in der sicherlich starken Selektion der Zielgruppe, was zu einer Einschr{\"a}nkung der Anwendbarkeit der Methode f{\"u}hrt.}, language = {de} } @inproceedings{Hessel2013, author = {Hessel, Franz}, title = {The relevance of the analytic validity of genetic tests in personalized medicine technologies for reimbursement decision making in Germany}, series = {EACME Annual Conference, Bochum}, booktitle = {EACME Annual Conference, Bochum}, year = {2013}, abstract = {Keine Angabe - No details}, language = {en} } @inproceedings{Hessel2013, author = {Hessel, Franz}, title = {Developing personalized medicine drugs: incentives for pharmaceutical companies}, series = {EACME Annual Conference, Bochum}, booktitle = {EACME Annual Conference, Bochum}, year = {2013}, abstract = {Objectives: Stratification of oncology drug therapy by genetic marker diagnostics can reveal additional patient benefit but also might influence the development process of drug manufacturers. The objective of this study is to identify and describe the most important incentives for pharmaceutical companies to develop personalized medicine drugs. Methods: To describe the main factors influencing the decision making process in the development of personalized medicine drugs we designed a qualitative systemdynamic model. The main factors influencing the process and their priority ranking were determined by systematic literature search, structured expert interviews with pharmaceutical companies, test manufacturers and other key stakeholders such as regulatory bodies, reimbursement decision makers and payers. The model was build with the Consideo iModeler software package. Results: In contrast to small companies big international companies constantly look for suitable companion diagnostic tests to select subgroups of high responder. The most important key factor for market success is the extent of clinical efficacy in comparison with competitors respectively the current treatment standard. Stratification of patient populations according to treatment response or frequency of adverse events using biomarker is regarded to increase clinical efficacy of the target indication. The test performance is important due to unsolved safety issues although not regarded as crucial for the success of the drug. In contrast to other stakeholders pharmaceutical companies did not consider personalized medicine to relevantly decrease development costs or marketing efforts respectively to increase the price potential for new drugs. A low prevalence of the remaining patient population after testing is not irrelevant but it is not seen as a factor which might lead to a stop of the development of a new drug by pharmaceutical companies. Conclusions: Genetic stratification is seen as a breakthrough in cancer therapy by pharmaceutical companies and physicians. Due to the current need for improvement of approval and reimbursement processes for personalized medicine approaches in oncology especially in Europe future sales are more difficult to predict.}, language = {en} } @inproceedings{ChlebusHahnenkampStrickeretal.2014, author = {Chlebus, Krysztof and Hahnenkamp, Klaus and Stricker, Monika and Tern{\`e}s, Anabel}, title = {Fachkr{\"a}ftesicherung in Life Sciences und Gesundheitswirtschaft}, year = {2014}, abstract = {Keine Angaben No details}, language = {de} } @inproceedings{Stantchev2015, author = {Stantchev, Vladimir}, title = {Towards Ambient IT in Healthcare}, year = {2015}, abstract = {Keine Angabe No details}, language = {en} } @inproceedings{Stantchev2015, author = {Stantchev, Vladimir}, title = {The Perspectives for IT in Healthcare: the Case of Spain and Germany}, year = {2015}, abstract = {Keine Angabe No details}, language = {en} } @inproceedings{Stantchev2015, author = {Stantchev, Vladimir}, title = {PrevenTAB: Towards Ambient IT in Healthcare}, year = {2015}, abstract = {Keine Angabe No details}, language = {en} } @inproceedings{Stantchev2015, author = {Stantchev, Vladimir}, title = {Requirements Engineering for Risk Management Solutions in Hospitals}, year = {2015}, abstract = {Keine Angabe No details}, language = {en} } @inproceedings{LopezGonzelezReyesRomero, author = {L{\´o}pez Gonz{\´e}lez, L. M. and Reyes, I. P. and Romero, Osvaldo}, title = {Efecto de la mezcla cachaza-vinaza en el rendimiento de metano y la estabilidad del proceso de dogesti{\´o}n anaerobia}, abstract = {Keine Angabe No details}, language = {es} } @inproceedings{Rozsa2014, author = {R{\´o}zsa, Julia}, title = {First International Conference on Innovation in Higher Education}, series = {Abstracts - presentations, posters and workshops}, booktitle = {Abstracts - presentations, posters and workshops}, publisher = {Heidelberger Hochschulverlag}, address = {Heidelberg}, organization = {SRH Hochschule Heidelberg}, isbn = {978-3-942648-09-7}, url = {http://nbn-resolving.de/urn:nbn:de:0298-opus4-11730}, pages = {2 -- 83}, year = {2014}, abstract = {This epaper contains abstracts of lectures held at SRH University for Applied Sciences, Heidelberg, December 2014. Now, 15 years after the beginning of the Bologna process (1999), it is time to re¬view the international educational landscape and evaluate its impact to date. How has teaching in higher education and in universities changed and what are the next steps? The International conference on innovation in higher education is intended to be a platform for knowledge transfer concerning the following issues: innovative teaching and learning methods in higher education, especially in the areas of architecture, business, engineering, informatics, psychology, social and legal sciences and therapeutic sciences, research-based teaching, change management and new organizational trends in higher education, international cooperation in teaching and research.}, language = {en} }